Phase 1 Trial Reveals Anecdotal Signs of Efficacy

0.1 mg/kg

Alfimeprase Infusion

Right

Posterior

Tibial

Artery

Pre-dose

45 minutes post-dose

Previous slide

Next slide

Back to first slide

View graphic version